Skip to content

Reduced Circulating 4 Hydroxyphenylpyruvate Dioxygenase Activity C4025587

Published: July 22, 2026Updated: August 20, 2026

Reduced 4-hydroxyphenylpyruvate dioxygenase activity affects tyrosine metabolism and can cause neurological symptoms. It is rare and managed with dietary restriction and supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
moderate
Chronic
true

Medication Comparisons

Compare medications used to treat Reduced Circulating 4 Hydroxyphenylpyruvate Dioxygenase Activity C4025587. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy